Janus Henderson Group
TPTX

Janus Henderson Group’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Janus Henderson Group’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-8,351
Closed -$629K – 2711
2022
Q2 		$629K Buy
8,351
+42
+0.5% +$1.87K ﹤0.01% 1612
2022
Q1 		$223K Buy
8,309
+2
+0% +$67 ﹤0.01% 2382
2021
Q4 		$397K Buy
8,307
+4,177
+101% +$187K ﹤0.01% 2036
2021
Q3 		$275K Buy
+4,130
New +$294K ﹤0.01% 1940

Janus Henderson Group's TPTX Position: Q3 2022 in Review

Janus Henderson Group sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 8,351 shares — an estimated $629K sold.

Janus Henderson Group first reported a position in TPTX in Q3 2021 and held it in 4 quarters. The position peaked at $629K in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

  • Janus Henderson Group reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Janus Henderson Group sold 8,351 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $629K.
  • Janus Henderson Group first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q3 2021 and held it in 4 quarters.
  • Janus Henderson Group's Turning Point Therapeutics, Inc. Common Stock position peaked at $629K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Janus Henderson Group's 13F filing for Q3 2022, filed 14 Nov 2022.